Condition: Prostate Cancer · Sponsor: Weill Medical College of Cornell University
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
This description comes directly from the study's public registry record.
May Ting, MBS · 732-757-2448 · mat7051@med.cornell.edu
Xiaohong Jing, PhD · 212-746-4739 · xij2004@med.cornell.edu
Always discuss trial participation with your own doctor first.
| Beckman Research Institute of City of Hope | Duarte, California, United States | Recruiting |
| Georgetown University | Washington D.C., District of Columbia, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| Beth Israel Deaconess Medical Center (BIDMC) | Boston, Massachusetts, United States | Recruiting |
| Hackensack Meridian Health | Hackensack, New Jersey, United States | Recruiting |
| NewYork-Presbyterian Queens | Flushing, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Weill Cornell Medicine | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05155501